Myricetin may provide protection against oxidative stress in type 2 diabetic erythrocytes

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 9-10, 2009, Pages 626-630

  Pandey, Kanti Bhooshan ^a   Mishra, Neetu ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Diabetes mellitus; Erythrocyte; Myricetin; Oxidative stress

Indexed keywords

EID: 70449556482     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-9-1004     Document Type: Article

References (20)

1. Abuja P. M. and Albertini R. (2001), Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306, 1-17.
2. Baynes J. W. (1991), Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
3. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., and Colombo R. (2003), Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329, 23-38.
4. Davies K. J. A. and Goldberg A. L. (1987), Oxygen free radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J. Biol. Chem. 262, 8220-8226.
5. Esterbauer H. and Cheeseman K. H. (1990), Determination of aldehydic lipid peroxidation products: Malondialdehyde and 4-hydroxynonenal. Methods Enzymol. 186, 407-413.
6. Facchini F. S., Humpherys M. H., DoNascimento C. A., Abbasi F., and Reaven G. M. (2000), Relation between insulin resistance and plasma concentration of lipid hydroperoxides, carotenoids and tocopherols. Am. J. Clin. Nutr. 72, 776-779.
7. Hollman P. C. and Katan M. B. (1999), Health effects and bioavailability of dietary flavonols. Free Radic. Res. 31, S75-S80.
8. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., Hakulinen T., and Aromaa A. (2002), Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76, 560-568.
9. Lee K.-H. and Choi E.-M. (2008), Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-D-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells. Eur. J. Pharmacol. 591, 1-6.
10. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S., and Stadtman E. R. (1990), Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-479.
11. Lowry O. H., Rosenbrough N. J., Farr A. L., and Randall R. J. (1951), Protein measurement with the Folinphenol reagent. J. Biol. Chem. 193, 265-275.
12. Marchesi V. T. and Palade G. E. (1967), The localization of Mg-Na-K activated adenosine triphosphate on red cell ghost membranes. J. Biol. Chem. 35, 385-404.
13. Ong K. C. and Khoo H. E. (1997), Biological effects of myricetin. Gen. Pharmacol. 29, 121-126.
14. Pandey K. B., Mishra N., and Rizvi S. I. (2009), Protective role of myricetin on markers of oxidative stress in human erythrocytes subjected to oxidative stress. Nat. Prod. Commun. 4, 221-226.
15. Pasaoglu H., Sancak B., and Bukan N. (2004), Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J. Exp. Med. 203, 211-218.
16. Rizvi S. I. and Zaid M. A. (2005), Impairment of sodium pump and Na/H exchanger in erythrocytes from noninsulin dependent diabetes mellitus patients: effect of tea catechins. Clin. Chim. Acta 354, 59-67.
17. Rizvi S. I. and Mishra N. (2009), Anti-oxidant effect of quercetin on type2 diabetic erythrocytes. J. Food Bio-chem. 33, 404-415.
18. Rizvi S. I., Zaid M. A., Anis R., and Mishra N. (2005), Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin. Exp. Pharmacol. Physiol. 32, 70-75.
19. Williamson G., Barron D., Shimoi K., and Terao J. (2005), In vitro biological properties of flavonoid conjugates found in vivo. Free Radic. Res. 39, 457-469.
20. Zelko I. N., Mariani T. J., and Folz R. J. (2002), Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC- SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33, 337-349.